Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterile alpha motif domain containing 4B (SAMD4B) is a widely expressed human protein composed of 694 amino acids, featuring a sterile alpha motif (SAM) domain that is crucial for RNA binding and transcriptional repression activity. Overexpression of SAMD4B suppresses the activity of major regulatory transcription factors including AP-1, p53, and p21, mainly via its SAM domain. SAMD4B regulates nuclear-transcribed mRNA poly(A) tail shortening and is active in the cytosol. In pathological contexts, particularly colorectal cancer, SAMD4B is a direct target of microRNA-451 (miR-451); decreased miR-451 results in elevated SAMD4B expression and is associated with increased tumor cell proliferation, migration, resistance to apoptosis, and reduced chemotherapy sensitivity, highlighting SAMD4B as a potential therapeutic target and biomarker for disease progression.
Drugs acting via downregulation of SAMD4B or modulation of the miR-451/SAMD4B axis may inhibit tumor cell proliferation and migration, and increase apoptosis and chemotherapy sensitivity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterile alpha motif domain containing 4B (SAMD4B).